| 标题 |
Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC expressing PD-L1 ≥50%: The PERSEE randomized phase III trial (GFPC 01-2020) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Renaud Descourt; Alice Mogenet; Maelys Consigny; Marie Bernardi; Romain Corre; et al 出版日期:2026-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)